Literature DB >> 15045511

Survival advantage of cultured human vascular endothelial cells that lost chromosome 13.

Masayuki Kimura1, Xiaojian Cao, Smita Patel, Abraham Aviv.   

Abstract

We explored the nature of chromosome 13 loss in cultured human vascular endothelial cells (HUVECs). Chromosome 13 loss detected by metaphase and interphase analysis was noted in earlier passages of HUVEC strains with no relation to telomere length or replicative senescence. Ectopic expression of telomerase did not influence the loss of chromosome 13. HUVECs losing chromosome 13 demonstrated increased migratory potential and loss of heterozygosity. Collectively, these observations suggest that the loss of chromosome 13 gives cultured HUVECs a replicative advantage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15045511     DOI: 10.1007/s00412-004-0276-6

Source DB:  PubMed          Journal:  Chromosoma        ISSN: 0009-5915            Impact factor:   4.316


  21 in total

1.  High-density SNP map of human ITR, a gene associated with vascular remodeling.

Authors:  Aritoshi Iida; Toshihiro Tanaka; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2003-02-20       Impact factor: 3.172

2.  Specific chromosome aberrations in senescent fibroblast cell lines derived from human embryos.

Authors:  P A Benn
Journal:  Am J Hum Genet       Date:  1976-09       Impact factor: 11.025

3.  Allelic imbalance on chromosomes 13 and 17 and mutation analysis of BRCA1 and BRCA2 genes in monozygotic twins concordant for breast cancer.

Authors:  A Försti; L Luo; I Vorechovsky; M Söderberg; P Lichtenstein; K Hemminki
Journal:  Carcinogenesis       Date:  2001-01       Impact factor: 4.944

4.  Age dependent aneuploidy and telomere length of the human vascular endothelium.

Authors:  H Aviv; M Y Khan; J Skurnick; K Okuda; M Kimura; J Gardner; L Priolo; A Aviv
Journal:  Atherosclerosis       Date:  2001-12       Impact factor: 5.162

5.  Human endothelial cell life extension by telomerase expression.

Authors:  J Yang; E Chang; A M Cherry; C D Bangs; Y Oei; A Bodnar; A Bronstein; C P Chiu; G S Herron
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

6.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

7.  Significance of the clonal and sporadic chromosome abnormalities in non-neoplastic renal tissue.

Authors:  R Casalone; P Granata Casalone; E Minelli; P Portentoso; R Righi; E Meroni; A Giudici; D Donati; C Riva; S Salvatore
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

8.  Karyotypic and phenotypic changes during in vitro aging of human endothelial cells.

Authors:  T E Johnson; D R Umbenhauer; R Hill; C Bradt; S N Mueller; E M Levine; W W Nichols
Journal:  J Cell Physiol       Date:  1992-01       Impact factor: 6.384

9.  CHC1-L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer.

Authors:  Alain Latil; Patrice Morant; Georges Fournier; Philippe Mangin; Philippe Berthon; Olivier Cussenot
Journal:  Int J Cancer       Date:  2002-06-10       Impact factor: 7.396

10.  Spontaneous chromosomal aberrations in cell cultures from patients with neurofibromatosis 1.

Authors:  H Kehrer; W Krone
Journal:  Mutat Res       Date:  1994-04-01       Impact factor: 2.433

View more
  2 in total

1.  Aneuploidy in immortalized human mesenchymal stem cells with non-random loss of chromosome 13 in culture.

Authors:  Masao Takeuchi; Kikuko Takeuchi; Yutaka Ozawa; Akihiro Kohara; Hiroshi Mizusawa
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-01-30       Impact factor: 2.416

2.  The Influence of C-Ions and X-rays on Human Umbilical Vein Endothelial Cells.

Authors:  Alexander Helm; Ryonfa Lee; Marco Durante; Sylvia Ritter
Journal:  Front Oncol       Date:  2016-01-20       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.